UTI Healthcare Fund (Equity, Equity Sectoral-pharma)

High
20 yrs 3 monthsStarted on:28 Jun 1999
₹ 381.91 Cras on: 23 Aug 2019
Long Term Horizon
2.69%
Capital Appreciation

Minimum Investment

  • ₹ 5000.00 for Lumpsum

Investment Objective

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Exit Load

Scheme Documents

Similar Funds
Reliance Pharma Fund
Current NAV 137.63
Return (CAGR) 18.79%
Value Research NA
SBI Healthcare Opportunities Fund
Current NAV 108.1
Return (CAGR) 14.01%
Value Research NA

Tenure

TenureReturns (CAGR)

SIP Returns

TenureReturns (CAGR)
10 YR6.12

Portfolio

Company Name% Assets
Sun Pharmaceutical Inds. Ltd.11.43
Divi's Laboratories Ltd.9.43
Dr. Reddy's Laboratories Ltd.9.09
Lupin Ltd.8.63
Cipla Ltd.7.51
Ipca Laboratories Ltd.7.27
Cadila Healthcare Ltd.6.08
Sanofi India Ltd.4.86
Torrent Pharmaceuticals Ltd.3.26
Natco Pharma Ltd.2.88

Top Sectoral Holdings

Sector Name% Assets
Healthcare94.46
Financial2.58

Indicators

LabelValue
Portfolio turnover ratio56
Standard Deviation15.24%
Beta0.86%

V Srivatsa

Mr. Srivatsa is a B.Com (H), Chartered Accountant, CWA. and PGDM from IIM Indore.
Prior to joining UTI in 2002 he has worked with Ford, Rhodes Parks & Co., Chartered Accountants and Madras Cements Ltd.

Other Funds Managed by V Srivatsa